Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 4:8:45.
doi: 10.3389/fnagi.2016.00045. eCollection 2016.

Astrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous System

Francisco Capani  1 , Cecilia Quarracino  2 , Roberto Caccuri  2 , Roberto E P Sica  2
Affiliations
Review

Astrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous System

Francisco Capani et al. Front Aging Neurosci. .

Abstract

Along the last years it has been demonstrated that non-neural cells play a major role in the pathogenesis of the primary degenerative disorders (PDDs) of the human central nervous system. Among them, astrocytes coordinate and participate in many different and complex metabolic processes, in close interaction with neurons. Moreover, increasing experimental evidence hints an early astrocytic dysfunction in these diseases. In this mini review we summarize the astrocytic behavior in PDDs, with special consideration to the experimental observations where astrocytic pathology precedes the development of neuronal dysfunction. We also suggest a different approach that could be consider in human investigations in Alzheimer's and Parkinson's disease. We believe that the study of PDDs with human brain samples may hold the key of a paradigmatic physiopathological process in which astrocytes might be the main players.

Keywords: astrocytes; human central nervous system; neurodegeneration; primary astrocytic degeneration; primary degenerative disorders.

PubMed Disclaimer

References

    1. Alexander K. S., Wu H. Q., Bruno J. P. (2012). Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine. Psychopharmac 220 627–637. 10.1007/s00213-011-2539-2 - DOI - PMC - PubMed
    1. Aronica E., Catania M. V., Geurts J., Yankaya B., Troost D. (2001). Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 105 509–520. 10.1016/S0306-4522(01)00181-6 - DOI - PubMed
    1. Braak H., Del Tredici K., Rüb U., de Vos R. A., Jansen Steur E. N., Braak E. (2003). Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24 197–211. 10.1016/S0197-4580(02)00065-9 - DOI - PubMed
    1. Bradford J., Shin J. Y., Roberts M., Wang C. E., Li X. J., Li S. (2009). Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc. Natl. Acad. Sci. U.S.A. 106 22480–22485. 10.1073/pnas.0911503106 - DOI - PMC - PubMed
    1. Broadstock M., Ballard C., Corbett A. (2014). Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies. Expert Opin. Pharmacother. 15 1797–1810. 10.1517/14656566.2014.936848 - DOI - PubMed